ZA985707B - Sertraline salts and sustained-release dosage forms of sertraline. - Google Patents

Sertraline salts and sustained-release dosage forms of sertraline.

Info

Publication number
ZA985707B
ZA985707B ZA9805707A ZA985707A ZA985707B ZA 985707 B ZA985707 B ZA 985707B ZA 9805707 A ZA9805707 A ZA 9805707A ZA 985707 A ZA985707 A ZA 985707A ZA 985707 B ZA985707 B ZA 985707B
Authority
ZA
South Africa
Prior art keywords
sertraline
sustained
dosage forms
release dosage
salts
Prior art date
Application number
ZA9805707A
Inventor
Mary Tanya Am Ende
William John Curatolo
Hylar Lewis Friedman
Ravi Mysore Shanker
Scott Max Herbig
Dwayne Thomas Friesen
James Blair West
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA985707B publication Critical patent/ZA985707B/en

Links

ZA9805707A 1997-07-01 1998-06-30 Sertraline salts and sustained-release dosage forms of sertraline. ZA985707B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5149897P 1997-07-01 1997-07-01

Publications (1)

Publication Number Publication Date
ZA985707B true ZA985707B (en) 2000-01-10

Family

ID=21971674

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9805707A ZA985707B (en) 1997-07-01 1998-06-30 Sertraline salts and sustained-release dosage forms of sertraline.

Country Status (3)

Country Link
CN (2) CN1907268A (en)
AP (2) AP2003002905A0 (en)
ZA (1) ZA985707B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109432038A (en) * 2018-12-28 2019-03-08 乐普制药科技有限公司 A kind of enteric coated tablet and preparation method thereof containing sertraline hydrochloride

Also Published As

Publication number Publication date
CN1823749A (en) 2006-08-30
CN1907268A (en) 2007-02-07
AP2003002905A0 (en) 2003-12-31
AP2002002662A0 (en) 2002-12-31

Similar Documents

Publication Publication Date Title
AP9801281A0 (en) Sertraline salts and sustained-release dosage forms of sertraline
GB9704069D0 (en) Paracetamol sustained-release formulation
ZA987551B (en) Solid pharmaceutical dosage forms
GB2296354B (en) Multithreaded processor
IL110014A0 (en) Solid controlled-release oral dosage forms
PL327403A1 (en) Novel agents exhibiting analgesic activity
AP9801173A0 (en) Rapidly releasing and taste-making pharmaceutical dosage
SG54525A1 (en) Multiphase soft gelatin dosage form
IL123647A0 (en) Substituted amino compounds their preparation and use
ZA985710B (en) Delayed-release dosage forms of sertraline.
ZA985709B (en) Encapsulated solution dosage forms of sertraline.
ZA985707B (en) Sertraline salts and sustained-release dosage forms of sertraline.
PL338781A1 (en) Dosage form
GB9512124D0 (en) Ammoxidation of propane
GB9704978D0 (en) Dosage forms
GB9719261D0 (en) Dosage forms
ZA963210B (en) Inhibiting photodecomposition of 3-substituted-2-oxindoles.
SI0980241T1 (en) Gelatine encapsulated solution dosage forms of sertraline
ZA97315B (en) Sustained-release formulation of methylphenidate.
IL120398A0 (en) Low dosage contraceptive
ZA968436B (en) Peptidyl compounds and their therapeutic use.
GB9724817D0 (en) Transdermal dosage form
GB9704350D0 (en) Compounds and their therapeutic use
GB9503709D0 (en) New pharmaceutical use
GB9505678D0 (en) New pharmaceutical use